53 related articles for article (PubMed ID: 23269549)
1. The unsulfated extracellular N-terminus of vGPCR reduces the tumorigenicity of hGRO-α in nude mice.
Wu H; Fu Y; Xiao J; Zhou M; Zhou W; Feng H
Sci China Life Sci; 2013 Jan; 56(1):26-31. PubMed ID: 23269549
[TBL] [Abstract][Full Text] [Related]
2. Sulfotyrosines of the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promote tumorigenesis through autocrine activation.
Feng H; Sun Z; Farzan MR; Feng P
J Virol; 2010 Apr; 84(7):3351-61. PubMed ID: 20106924
[TBL] [Abstract][Full Text] [Related]
3. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma.
Montaner S; Sodhi A; Ramsdell AK; Martin D; Hu J; Sawai ET; Gutkind JS
Cancer Res; 2006 Jan; 66(1):168-74. PubMed ID: 16397229
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus K7 induces viral G protein-coupled receptor degradation and reduces its tumorigenicity.
Feng H; Dong X; Negaard A; Feng P
PLoS Pathog; 2008 Sep; 4(9):e1000157. PubMed ID: 18802460
[TBL] [Abstract][Full Text] [Related]
5. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma.
Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA
PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumorigenicity of fibroblasts transformed with human herpesvirus 8 chemokine receptor vGPCR by successive passage in nude and immunocompetent mice.
Thirunarayanan N; Cifire F; Fichtner I; Posner S; Benga J; Reiterer P; Kremmer E; Kölble K; Lipp M
Oncogene; 2007 Aug; 26(39):5702-12. PubMed ID: 17353903
[TBL] [Abstract][Full Text] [Related]
7. Glycosylation of KSHV encoded vGPCR functions in its signaling and tumorigenicity.
Wu H; Liu L; Xiao J; Chi M; Qu Y; Feng H
Viruses; 2015 Mar; 7(4):1627-41. PubMed ID: 25835533
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation and polyubiquitination of transforming growth factor beta-activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor.
Bottero V; Kerur N; Sadagopan S; Patel K; Sharma-Walia N; Chandran B
J Virol; 2011 Mar; 85(5):1980-93. PubMed ID: 21159881
[TBL] [Abstract][Full Text] [Related]
9. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
10. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
11. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells.
Cannon ML; Cesarman E
Oncogene; 2004 Jan; 23(2):514-23. PubMed ID: 14724579
[TBL] [Abstract][Full Text] [Related]
12. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.
Liang Y; Ganem D
J Virol; 2004 Jul; 78(13):6818-26. PubMed ID: 15194757
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase is required for KSHV vGPCR signaling.
He M; Bakken T; Kassimova A; Boshoff C; Philpott N; Cannon ML
Mol Carcinog; 2012 Apr; 51(4):339-51. PubMed ID: 21538577
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of T cells by γ2-herpesviral GPCR through the interaction with cellular CXCR4.
Kwon EK; Min CK; Kim Y; Lee JW; Aigerim A; Schmidt S; Nam HJ; Han SK; Kim K; Cha JS; Kim H; Kim S; Cho HS; Choi MS; Cho NH
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):1-11. PubMed ID: 27751885
[TBL] [Abstract][Full Text] [Related]
15. Cell transformation mediated by the Epstein-Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling.
Lyngaa R; Nørregaard K; Kristensen M; Kubale V; Rosenkilde MM; Kledal TN
Oncogene; 2010 Aug; 29(31):4388-98. PubMed ID: 20543866
[TBL] [Abstract][Full Text] [Related]
16. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor.
Burger M; Burger JA; Hoch RC; Oades Z; Takamori H; Schraufstatter IU
J Immunol; 1999 Aug; 163(4):2017-22. PubMed ID: 10438939
[TBL] [Abstract][Full Text] [Related]
17. The guanine exchange factor SWAP70 mediates vGPCR-induced endothelial plasticity.
Dwyer J; Azzi S; Leclair HM; Georges S; Carlotti A; Treps L; Galan-Moya EM; Alexia C; Dupin N; Bidère N; Gavard J
Cell Commun Signal; 2015 Feb; 13():11. PubMed ID: 25889342
[TBL] [Abstract][Full Text] [Related]
18. The Galpha12/13 family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis.
Martín MJ; Tanos T; García AB; Martin D; Gutkind JS; Coso OA; Marinissen MJ
J Biol Chem; 2007 Nov; 282(47):34510-24. PubMed ID: 17881360
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR.
Krause CJ; Popp O; Thirunarayanan N; Dittmar G; Lipp M; Müller G
Oncotarget; 2016 Mar; 7(9):10414-32. PubMed ID: 26871287
[TBL] [Abstract][Full Text] [Related]
20. Lymphatic reprogramming by Kaposi sarcoma herpes virus promotes the oncogenic activity of the virus-encoded G-protein-coupled receptor.
Aguilar B; Choi I; Choi D; Chung HK; Lee S; Yoo J; Lee YS; Maeng YS; Lee HN; Park E; Kim KE; Kim NY; Baik JM; Jung JU; Koh CJ; Hong YK
Cancer Res; 2012 Nov; 72(22):5833-42. PubMed ID: 22942256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
